AI PET scans for T-NK cell lymphoma
Part of Cancer clinical trials.
This study uses artificial intelligence to analyze PET/CT scans from people with T-NK cell lymphoma. It aims to improve diagnosis, predict how well treatment will work, and forecast outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with T-NK cell lymphoma (a type of lymphoma).
- You have had a PET/CT scan before starting treatment.
- You are receiving or will receive standard treatment.
- Your medical records and follow-up information are complete.
- You have not had any prior cancer treatment.
- You have no other current or past cancers.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a special PET scan to look for a protein called Granzyme B in your body, which may help predict how well treatment will work in T-NK cell lymphoma. It aims to see if this imaging can guide treatment decisions.
This trial studies whether special imaging with PET/MR can help stage (find the extent of) and evaluate treatment effectiveness in people newly diagnosed with NK/T-cell lymphoma. It may help doctors choose the right treatment plan and track how well therapy is working.
This trial uses artificial intelligence to predict if early-stage lung cancer has spread to nearby lymph nodes. It aims to help doctors make better treatment decisions for patients with stage 1 lung cancer.
This trial looks at whether PET/CT scans can better predict outcomes in people with fast-growing lymphoma. If you are newly diagnosed and receiving standard treatment, the study may help refine how response is evaluated.
This study uses an AI system that looks at your PET/CT scan images to figure out the exact type and genetic makeup of your non-small cell lung cancer. The goal is to improve how doctors classify and treat your cancer without needing extra invasive tests.
This trial tests whether a computer model can accurately detect if cancer has spread to lymph nodes in patients with nasopharyngeal carcinoma. It uses MRI and PET/CT scans taken before treatment to see if the AI can replace or supplement current methods.
Hear when a new T-NK Cell Lymphoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.